| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GSE167528
|
||||||||
| GSM5106721 |
uninfected sample at time = 0 hours; replicate 1
|
SRA | 1 |
|
Matthew Weirauch | Feb 26, 2021 | |||
| GSM5106722 |
uninfected sample at time = 0 hours; replicate 2
|
SRA | 1 |
|
Matthew Weirauch | Feb 26, 2021 | |||
| GSM5106723 |
uninfected sample at time = 0 hours; replicate 3
|
SRA | 1 |
|
Matthew Weirauch | Feb 26, 2021 | |||
| GSM5106724 |
SARS-CoV-2-infected sample at time = 8 hours; replicate 1
|
SRA | 1 |
|
Matthew Weirauch | Feb 26, 2021 | |||
| GSM5106725 |
SARS-CoV-2-infected sample at time = 8 hours; replicate 2
|
SRA | 1 |
|
Matthew Weirauch | Feb 26, 2021 | |||
| GSM5106726 |
SARS-CoV-2-infected sample at time = 8 hours; replicate 3
|
SRA | 1 |
|
Matthew Weirauch | Feb 26, 2021 | |||
| GSM5106727 |
SARS-CoV-2-infected sample at time = 24 hours; replicate 1
|
SRA | 1 |
|
Matthew Weirauch | Feb 26, 2021 | |||
| GSM5106728 |
SARS-CoV-2-infected sample at time = 24 hours; replicate 2
|
SRA | 1 |
|
Matthew Weirauch | Feb 26, 2021 | |||
| GSM5106729 |
SARS-CoV-2-infected sample at time = 24 hours; replicate 3
|
SRA | 1 |
|
Matthew Weirauch | Feb 26, 2021 | |||
| GSM5106730 |
pooled sample used for control
|
SRA | 1 |
|
Matthew Weirauch | Feb 26, 2021 |
